1. Long-term outcome of repaired tetralogy of Fallot: Survival, tachyarrhythmia, and impact of pulmonary valve replacement.
- Author
-
Wu MH, Wang JK, Chiu SN, Lu CW, Lin MT, Chen CA, and Tseng WC
- Subjects
- Humans, Young Adult, Adult, Retrospective Studies, Treatment Outcome, Arrhythmias, Cardiac, Death, Sudden, Cardiac etiology, Tetralogy of Fallot complications, Tetralogy of Fallot surgery, Pulmonary Valve surgery, Heart Valve Prosthesis Implantation adverse effects, Tachycardia, Ventricular etiology, Tachycardia, Ventricular surgery
- Abstract
Background: Pulmonary valve replacement (PVR) is recommended for severe pulmonary regurgitation in repaired tetralogy of Fallot (rTOF)., Objective: The purpose of this study was to investigate the event rate and effectiveness of PVR., Methods: A retrospective study of tetralogy of Fallot patients who survived total repair from 1970 to 2020 was conducted., Results: We identified 1744 rTOF patients; 86.6% with classic rTOF, 11.5% with pulmonary atresia, 0.8% with endocardial cushion defect, and 1.1% with absent pulmonary valve. Annual risks of tachyarrhythmia/sudden cardiac arrest (SCA) increased to 0.295% and 1.338% in patients aged 10-30 and 30-60 years, respectively, without sex predominance. PVR (223 surgical and 39 percutaneous) event rate was 34.7% ± 2.1% by 30 years after repair (annual risk: 1.57% between 10 and 30 years after repair). The second PVR rate was 9.9% ± 4.1% by 20 years after the first PVR. Tachyarrhythmia/SCA risk was higher in PVR patients than in No PVR patients and was reduced in PVR patients without tachyarrhythmia/SCA before PVR. However, survival in patients with ventricular tachyarrhythmia/SCA still was better after PVR. At PVR, 13% of patients had tachyarrhythmia/SCA, which was the major predictor of events after PVR. Before PVR, although the ventricular tachyarrhythmia/SCA risks included QRS duration >160 ms and New York Heart Association functional class III or IV, supraventricular tachyarrhythmia was associated with PVR age ≥28 years and N-terminal pro-brain natriuretic peptide >450 pg/mL., Conclusion: Tachyarrhythmia/SCA occurrence and the need for PVR increased with age during young adulthood. PVR reduced subsequent arrhythmias only in those patients without arrhythmias before PVR., (Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF